StockWatch: Wave’s RNA Editing Milestone Lifts Korro, ProQR
Wave Life Sciences (WVE) was not the only developer of RNA editing therapies to show significant stock gains from its historic proof-of-mechanism for its RNA editing platform, shown recently in the first-ever clinical demonstration...
New technique enhances understanding of chromatin organization
Researchers at the University of California San Diego Center for Epigenomics (C4E) have developed a new technique, called Droplet Hi-C, that allows scientists to rapidly determine chromatin organization, the arrangement of genetic material within...
Progeria’s Cardiovascular Complications Could Be Treated with New Protein Finding
The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes accelerated aging in children, and for...
Ubiquigent partners with Alleo Labs to advance DUB-targeting therapies
Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced a strategic partnership with Alleo Labs Corp. (“Alleo”),...
Confessions of a Grizzled Biotech Survivor
“We wish to suggest a structure for the salt of deoxyribose nucleic acid (D.N.A.). This structure has novel features which are of considerable biological interest.”
Those famously understated words introduced a research paper written by...
Brazil-Italy joint lab focuses on Alzheimer’s drug development
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the...
Immusoft Reports Promising Early Data for Lead Candidate in MPS I
Immusoft CEO Sean Ainsworth
Nearly a year after making cell therapy history by dosing the first patient with the first engineered B cell in a human trial, Immusoft has reported promising but early clinical data...
Single-Cell Analysis of Prenatal Skin and Skin Organoids Offers Scarless Skin Repair Clues
Researchers at the Wellcome Sanger Institute and Newcastle University, together with a team of international collaborators, have created a single-cell atlas of prenatal human skin, and a “mini organ” of skin in a dish...
Nuclera closes $75 million USD financing
Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million). The fundraise was led by...
Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced a strategic partnership with Alleo Labs Corp. (“Alleo”),...
